文献速递主动脉疾病

慢性肾脏病与终末期肾病对复杂主动脉瘤腔内及开放修复术后结局的影响

Impact of chronic kidney disease and end-stage renal disease on outcomes after complex endovascular and open aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2023-12-27

基于血管质量倡议(VQI)2003年1月至2020年9月7849例择期复杂腹主动脉瘤修复(4230例开放修复、3619例开窗/分支腔内修复),按CKD分级分层。CKD加重与术后1年死亡率独立相关,透析患者F-BEVAR后1年生存风险HR 4.4。作者认为中重度CKD及终末期肾病患者择期修复阈值应提高。

要点

  • 复杂AAA修复后CKD严重程度是围术期及1年死亡的重要预测因素,与治疗方式无关。
  • F-BEVAR后透析患者1年生存HR 4.4(95%CI 2.53-7.72),CKD 3b HR 2.5。
  • 开放修复后CKD 4-5 HR 3.4(95%CI 2.03-5.79),透析未显示独立关联。

核心结论

  • CKD严重程度是复杂AAA修复后围术期及1年死亡的重要预测因素,与治疗方式无关,可能反映CKD自然病程。
  • 作者认为中重度CKD及终末期肾病患者1年死亡率高,应考虑提高择期AAA修复阈值。

研究设计与样本

  • 分析血管质量倡议(VQI)2003年1月至2020年9月所有因复杂AAA行择期开放修复或开窗/分支腔内修复且有术前肾功能数据的患者。
  • 按CKD分级分层:正常/轻度(CKD 1-2)、中度(CKD 3a)、中重度(CKD 3b)、重度(CKD 4-5)及透析。
  • 复杂开放修复仅纳入阻断部位高于一侧肾动脉的患者;F-BEVAR纳入近端锚定区低于5区(腹腔干以上)者,排除远端锚定区在1至5区之间者。
  • 主要结局为围术期及1年死亡率,采用Cox多因素回归模型识别死亡预测因素。

主要发现

  • 共纳入7849例择期复杂AAA修复:开放修复4230例(54%),F-BEVAR 3619例(46%)。
  • 多数患者为白人(89%)和男性(74%),平均年龄72±8岁;F-BEVAR患者更年长且合并症更多。
  • 复杂AAA择期F-BEVAR始于2012年,占比从2012年1.4%增至2020年58%(P<.001)。
  • 开放修复组围术期并发症更多,但1年死亡率更低;正常/轻度CKD组在两种修复方式后1年生存率均最高。
  • F-BEVAR后与CKD 1-2相比,CKD 3b(HR 2.5,95%CI 1.82-3.40,P<.001)、CKD 4-5(HR 1.9,95%CI 1.16-3.26,P=.011)及透析(HR 4.4,95%CI 2.53-7.72,P<.001)与1年生存独立相关。

临床怎么用

  • 作者认为中重度CKD及终末期肾病患者择期复杂AAA修复1年死亡率高,应考虑提高择期修复阈值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Chronic kidney disease (CKD) and end-stage renal disease are traditionally associated with worse outcomes after endovascular aortic repair (EVAR) and open aneurysm repair (OAR) of abdominal aortic aneurysms (AAAs). However, there needs to be more data on complex AAA repair involving the aorta's visceral segment. This study stratifies complex AAA repair outcomes by CKD severity and dialysis dependence. METHODS: All patients undergoing elective OAR and fenestrated/branched EVAR (F-BEVAR) for complex AAA with preoperative renal function data captured by the Vascular Quality Initiative between January 2003 and September 2020 were analyzed. Patients were stratified by CKD class as follows: normal/mild (CKD 1 and 2), moderate (CKD class 3a), moderate to severe (CKD 3b), severe (CKD class 4 and 5), and dialysis. Only patients with clamp sites above one of the renal arteries were included for complex OAR. For F-BEVAR, patients with proximal landing zones below zone 5 (above celiac artery) were included, and distal landing zones between zones 1 and 5 were excluded. Primary outcomes were perioperative and 1-year mortality. Predictors of mortality were identified by Cox multivariate regression models. RESULTS: We identified 7849 elective complex AAA repairs: 4230 (54%) complex OARs and 3619 (46%) F-BEVARs. Most patients were White (89%) and male (74%), with an average age of 72 ± 8 years. The patients who underwent F-BEVAR were older and had more comorbidities. Elective F-BEVAR for complex AAA started in 2012 and increased from 1.4% in 2012 to 58% in 2020 (P < .001). The OAR cohort had more perioperative complications, but less 1-year mortality. The normal/mild CKD cohort had the highest 1-year survival compared with other groups after both complex OAR and F-BEVAR. On Cox regression analysis, when compared with CKD 1-2, worsening CKD stage (CKD 3b: hazard ratio [HR], 2.5; 95% confidence interval [CI], 1.82-3.40; P < .001; CKD 4-5: HR, 1.9; 95% CI, 1.16-3.26; P = .011; and dialysis: HR, 4.4; 95% CI, 2.53-7.72; P < .001) were independently associated with 1-year survival after F-BEVAR. After complex OAR, worsening CKD stage but not dialysis was associated with 1-year mortality compared with CKD 1-2 (CKD 3b: HR, 1.6; 95% CI, 1.13-2.35; P = .009; CKD 4-5: HR, 3.4; 95% CI, 2.03-5.79; P < .001). CONCLUSIONS: CKD severity is an essential predictor of perioperative and 1-year mortality after complex AAA repair, irrespective of the treatment modality, which may reflect the natural history of CKD. Consideration should be given to raising the threshold for elective AAA repair in patients with moderate to severe CKD and end-stage renal disease, given the high 1-year mortality rate.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Scott CK, Pizano A, Colon JP, et al. Impact of chronic kidney disease and end-stage renal disease on outcomes after complex endovascular and open aortic aneurysm repair. J Vasc Surg. 2023. PMID: 38157993. doi:10.1016/j.jvs.2023.12.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。